Trevi Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 11/14/2025 | 13.22 M | $120.98 M | 0.00% | 10.14% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 10.26 M | $93.87 M | 0.00% | 7.87% |
| BLACKROCK, INC. | 11/12/2025 | 9.90 M | $90.59 M | 20.67% | 7.60% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/14/2025 | 8.53 M | $78.07 M | 0.00% | 6.55% |
| VANGUARD GROUP INC | 11/07/2025 | 5.83 M | $53.32 M | 9.60% | 4.47% |
| VIKING GLOBAL INVESTORS LP | 11/14/2025 | 5.13 M | $46.93 M | 232.40% | 3.93% |
| VIVO CAPITAL, LLC | 11/14/2025 | 5.09 M | $46.62 M | 13.52% | 3.91% |
| MARSHALL WACE, LLP | 11/13/2025 | 4.84 M | $44.30 M | 95.40% | 3.71% |
| MORGAN STANLEY | 11/14/2025 | 4.30 M | $39.36 M | 320.09% | 3.30% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 4.29 M | $39.28 M | 0.26% | 3.29% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 3.41 M | $31.17 M | 0.00% | 2.61% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 3.31 M | $30.27 M | 0.00% | 2.54% |
| FMR LLC | 11/13/2025 | 3.30 M | $30.19 M | 795.42% | 2.53% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 3.25 M | $29.77 M | 1,791.99% | 2.50% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2025 | 2.82 M | $25.76 M | -23.34% | 2.16% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 2.80 M | $25.62 M | 10.49% | 2.15% |
| SIREN, L.L.C. | 11/13/2025 | 2.54 M | $23.21 M | -35.59% | 1.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.22 M | $20.33 M | 24.29% | 1.70% |
| STATE STREET CORP | 11/14/2025 | 2.22 M | $20.31 M | 21.09% | 1.70% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 2.20 M | $20.13 M | 158.82% | 1.69% |
| ACORN CAPITAL ADVISORS, LLC | 11/17/2025 | 2.14 M | $19.63 M | 0.00% | 1.65% |
| ARTIA GLOBAL PARTNERS LP | 11/14/2025 | 2.00 M | $18.30 M | 52.43% | 1.53% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.84 M | $16.81 M | 67.37% | 1.41% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 1.60 M | $14.65 M | 1,154.65% | 1.23% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 1.41 M | $12.91 M | 31.05% | 1.08% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 1.38 M | $12.64 M | 0.00% | 1.06% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 11/13/2025 | 1.26 M | $11.50 M | 9.66% | 0.96% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 10/10/2025 | 1.05 M | $9.59 M | 1,105.38% | 0.80% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 941.93 K | $8.62 M | -45.51% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 806.33 K | $7.38 M | 256.89% | 0.62% |
| J. GOLDMAN & CO LP | 11/14/2025 | 792.81 K | $7.25 M | -19.03% | 0.61% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 787.45 K | $7.21 M | 163.32% | 0.60% |
| NORTHERN TRUST CORP | 11/14/2025 | 736.93 K | $6.74 M | 27.83% | 0.57% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 727.60 K | $6.66 M | 362.72% | 0.56% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 717.60 K | $6.57 M | 618.32% | 0.55% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 651.68 K | $5.96 M | 45.51% | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 643.96 K | $5.89 M | -19.50% | 0.49% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 626.46 K | $5.73 M | -73.39% | 0.48% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 10/23/2025 | 620.46 K | $5.68 M | 100.00% | 0.48% |
| PRUDENTIAL FINANCIAL INC | 11/13/2025 | 602.65 K | $5.51 M | 166.21% | 0.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 588.79 K | $5.39 M | 9.12% | 0.45% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2025 | 570.47 K | $5.22 M | 0.13% | 0.44% |
| EAM INVESTORS, LLC | 11/14/2025 | 549.48 K | $4.97 M | 12.92% | 0.42% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 11/14/2025 | 525.00 K | $4.80 M | 0.00% | 0.40% |
| INVESCO LTD. | 11/13/2025 | 483.07 K | $4.42 M | 49.86% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 412.70 K | $3.78 M | -9.75% | 0.32% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 390.00 K | $3.57 M | 0.00% | 0.30% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 350.71 K | $3.21 M | 100.00% | 0.27% |
| UBS GROUP AG | 11/13/2025 | 298.61 K | $2.73 M | -15.70% | 0.23% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 293.30 K | $2.68 M | -40.06% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Trevi Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 194 institutional investors and hedge funds held shares of Trevi Therapeutics, Inc.. The most heavily invested institutionals were:
NEA Management Company, LLC: 13.22 M
Frazier Life Sciences Management, L.P.: 10.26 M
BlackRock, Inc.: 9.9 M
Rubric Capital Management LP: 8.53 M
VANGUARD GROUP INC: 5.83 M
VIKING GLOBAL INVESTORS LP: 5.13 M
99.21% of Trevi Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 137.49 M shares in the last 24 months. This purchase volume represents approximately $1.85 B in transactions.